Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

344
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
344
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

139
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
Drug Delivery: Overview01:16

Drug Delivery: Overview

294
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
294
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis.

International journal of molecular sciences·2026
Same author

Valorization of Olive Stones: Chemical Composition and Bioactivity.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Making Mealtime Easier: Nutrition and Texture in Foods for the Elderly with Swallowing Difficulties in Formal and Informal Care.

Foods (Basel, Switzerland)·2026
Same author

Chromatography and Mass Spectrometry: Evolving Techniques for Food Analysis.

Foods (Basel, Switzerland)·2025
Same author

Exploring Biosurfactants as Antimicrobial Approaches.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials.

Pharmaceutics·2024

Related Experiment Video

Updated: Jul 5, 2025

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers
09:02

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers

Published on: August 10, 2020

7.5K

Triterpenes Drug Delivery Systems, a Modern Approach for Arthritis Targeted Therapy.

Célia Faustino1, Noélia Duarte1, Lídia Pinheiro1

  • 1Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-003 Lisbon, Portugal.

Pharmaceuticals (Basel, Switzerland)
|January 23, 2024
PubMed
Summary
This summary is machine-generated.

Natural triterpenoids show promise for arthritis treatment but suffer from poor bioavailability. Nanocarrier drug delivery systems (DDSs) offer a solution by improving triterpenoid pharmacokinetics and enabling targeted arthritis therapy.

Keywords:
arthritisdrug delivery systemsgoutosteoarthritistriterpenes

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

149
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

119

Related Experiment Videos

Last Updated: Jul 5, 2025

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers
09:02

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers

Published on: August 10, 2020

7.5K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

149
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

119

Area of Science:

  • Pharmacology
  • Drug Delivery
  • Natural Products

Background:

  • Arthritis is a leading cause of disability, with current treatments like disease-modifying anti-rheumatic drugs (DMARDs) posing risks with long-term use.
  • Triterpenoids, natural compounds with anti-inflammatory effects, demonstrate efficacy in preclinical arthritis models but face bioavailability challenges (low solubility, rapid metabolism).

Purpose of the Study:

  • To review nanocarrier-based drug delivery systems (DDSs) for enhancing triterpenoid therapy in arthritis.
  • To explore advancements in nanocarrier DDSs for osteoarthritis (OA), rheumatoid arthritis (RA), and gout over the past decade.

Main Methods:

  • Literature review of studies published in the last ten years.
  • Focus on nanocarrier DDSs including polymeric nanoparticles, micelles, liposomes, nanoemulsions, and hydrogels.
  • Analysis of triterpenoid delivery systems for arthritis treatment.

Main Results:

  • Various nanocarrier DDSs (polymeric nanoparticles, micelles, liposomes, nanoemulsions, hydrogels) have been developed for triterpenoid delivery.
  • These DDSs improve triterpenoid pharmacokinetic profiles and enable sustained drug release.
  • Nanocarrier systems show superior therapeutic effects in arthritis models compared to free triterpenoids, with a safety profile comparable to existing drugs.

Conclusions:

  • Nanocarrier DDSs are effective alternatives for delivering anti-arthritic triterpenoids, overcoming bioavailability limitations.
  • These advanced systems offer targeted delivery and improved therapeutic outcomes for various forms of arthritis.
  • Further research into nanocarrier DDSs holds significant potential for developing safer and more effective arthritis treatments.